Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-05 4:43 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
16,632 | $1.7107 | $28,452 | 295,474 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 4:40 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,618 | $2.0774 | $3,361 | 312,106 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:18 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,555 | $3.4247 | $5,325 | 313,724 (Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 4:17 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
12,191 | $5.4956 | $66,997 | 315,279 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-05 8:00 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
77,824 | $9.4172 | $732,884 | 719,570 (Direct) |
View |
| 2023-06-05 Sale |
2023-06-07 4:30 pm |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
6,486 | $9.5032 | $61,638 | 130,169 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-08 Option Award |
2025-03-27 4:37 pm |
N/A 2035-03-07 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,003,000 | $0 | 1,003,000 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 4:30 pm |
N/A 2034-06-20 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-03-02 Option Award |
2024-03-05 8:00 pm |
N/A 2034-03-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
667,225 | $0 | 719,570 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 5:12 pm |
N/A 2033-06-22 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:30 pm |
N/A 2033-03-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
200,000 | $0 | 286,655 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-27 6:10 pm |
N/A 2032-06-23 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:44 pm |
N/A 2032-06-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,036,864 | $0 | 1,036,864 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 4:32 pm |
N/A 2032-05-25 |
Aptinyx Inc. | APTX | O'Neill Gilmore Neil Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-22 4:19 pm |
N/A 2031-10-18 |
Aptinyx Inc. | APTX | O'Neill Gilmore Neil Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:26 pm |
N/A 2031-06-23 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
13,425 | $0 | 13,425 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
15,000 | $0 | 28,546 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
524 | $86.97 | 28,546 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:05 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
75,000 | $0 | 89,070 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 5:16 pm |
N/A 2030-12-09 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-12-14 5:10 pm |
N/A 2030-06-17 |
Unity Biotechnology Inc. | UBX | O'Neill Gilmore Neil Director |
0 | $0 | 40,000 (Direct) |
View |